Jacques Vargaftig

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction

David Taussig, Jacques Vargaftig, Farideh Miraki‐Moud et al. · Blood · 2010 · 359 citations · Full text

Medicine, Hematology, Oncology +13

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

Nicolas Delanoy, Jean‐Marie Michot, Thibault Comont et al. · The Lancet Haematology · 2018 · 292 citations

Pharmacy, Hematology, Immunology +16

Age-related changes in human hematopoietic stem/progenitor cells

Klaudia Kuranda, Jacques Vargaftig, Philippe De La Rochère et al. · Aging Cell · 2011 · 171 citations

Life Sciences, Cell Biology, Hematology +16

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé et al. · Blood Advances · 2019 · 121 citations · Full text

Medicine, Hematology, Oncology +17

A Niche-Like Culture System Allowing the Maintenance of Primary Human Acute Myeloid Leukemia-Initiating Cells: A New Tool to Decipher Their Chemoresistance and Self-Renewal Mechanisms

Emmanuel Griessinger, Fernando Anjos‐Afonso, Irene Pizzitola et al. · Stem Cells Translational Medicine · 2014 · 112 citations · Full text

Medicine, Cell Biology, Oncology +17